Genito-Urinary Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Urologicals, Hormonal Therapy, Gynecological, Anti-infectives, Others); Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Sexually Transmitted Diseases, Others)

Report Code: TIPRE00021893 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Genitourinary disorders are the conditions that deals with genital and urinary system. Genitourinary drugs are used to treat disorders related to kidney, ureters, bladder and urethra. The diagnosis of the genitourinary system involves the entire urinary tract and male genital tract. Genitourinary infections may be communicable and caused by organisms such as bacteria or yeast. It is estimated that one in five women will suffer from urinary tract infection in her lifetime. Antibiotics are the first line of treatment for urinary tract infections. Genitourinary cancers are cancer in the urinary system e.g. prostate cancer, ovarian cancer, bladder cancer and cervical cancer. Growing incidence of genitourinary disorder will drive genitourinary drug market.

MARKET DYNAMICS

Genito-urinary drugs market is driving due to factors such as growing prevalence of genitourinary disorders and increasing number of pipeline drugs. However, the influx of a wide range of counterfeit and generics launched by big pharmaceutical companies as well as small and medium-sized drug manufacturers are likely to create a negative impact on the growth of this market.

MARKET SCOPE

The Genito-urinary drugs market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Genito-urinary drugs Market with detailed market segmentation by product and indication. The Genito-urinary drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Genito-urinary drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Genito-urinary drugs market is segmented based on product and indication. Based on product, market is segmented as Urological, Hormonal Therapy, Gynecological, Anti-infectives, Others. Based on indication, market is segmented as Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Sexually Transmitted Diseases, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Genito-urinary drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genito-urinary drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Genito-urinary drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genito-urinary drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Genito-urinary drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Genito-urinary drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Genito-urinary drugs in the global market. Below mentioned is the list of few companies engaged in the Genito-urinary drugs Market.

The report also includes the profiles of key players in Genito-urinary drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Melinta Therapeutics Inc.
  •   Cipla USA Inc.
  •   Allergan PLC
  •   Merck & Co. Inc.
  •   Pfizer Inc.
  •   Astellas Pharma
  •   GlaxoSmithKline plc
  •   Teva Pharmaceutical Industries Ltd.
  •   AstraZeneca
  •   Bristol-Myers Squibb Company
  •   Novartis AG
  •   Eli Lilly and Company
  •   Advanz Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genito-urinary Drugs Market - By Product
1.3.2 Genito-urinary Drugs Market - By Indication
1.3.3 Genito-urinary Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENITO-URINARY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENITO-URINARY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENITO-URINARY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GENITO-URINARY DRUGS - GLOBAL MARKET OVERVIEW
6.2. GENITO-URINARY DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. GENITO-URINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. UROLOGICALS
7.3.1. Overview
7.3.2. Urologicals Market Forecast and Analysis
7.4. HORMONAL THERAPY
7.4.1. Overview
7.4.2. Hormonal Therapy Market Forecast and Analysis
7.5. GYNECOLOGICAL
7.5.1. Overview
7.5.2. Gynecological Market Forecast and Analysis
7.6. ANTI-INFECTIVES
7.6.1. Overview
7.6.2. Anti-infectives Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. GENITO-URINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. PROSTATE CANCER
8.3.1. Overview
8.3.2. Prostate Cancer Market Forecast and Analysis
8.4. OVARIAN CANCER
8.4.1. Overview
8.4.2. Ovarian Cancer Market Forecast and Analysis
8.5. BLADDER CANCER
8.5.1. Overview
8.5.2. Bladder Cancer Market Forecast and Analysis
8.6. CERVICAL CANCER
8.6.1. Overview
8.6.2. Cervical Cancer Market Forecast and Analysis
8.7. RENAL CANCER
8.7.1. Overview
8.7.2. Renal Cancer Market Forecast and Analysis
8.8. ERECTILE DYSFUNCTION
8.8.1. Overview
8.8.2. Erectile Dysfunction Market Forecast and Analysis
8.9. URINARY TRACT INFECTIONS
8.9.1. Overview
8.9.2. Urinary Tract Infections Market Forecast and Analysis
8.10. SEXUALLY TRANSMITTED DISEASES
8.10.1. Overview
8.10.2. Sexually Transmitted Diseases Market Forecast and Analysis
8.11. OTHERS
8.11.1. Overview
8.11.2. Others Market Forecast and Analysis
9. GENITO-URINARY DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Genito-urinary Drugs Market Overview
9.1.2 North America Genito-urinary Drugs Market Forecasts and Analysis
9.1.3 North America Genito-urinary Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Genito-urinary Drugs Market Forecasts and Analysis - By Indication
9.1.5 North America Genito-urinary Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Genito-urinary Drugs Market
9.1.5.1.1 United States Genito-urinary Drugs Market by Product
9.1.5.1.2 United States Genito-urinary Drugs Market by Indication
9.1.5.2 Canada Genito-urinary Drugs Market
9.1.5.2.1 Canada Genito-urinary Drugs Market by Product
9.1.5.2.2 Canada Genito-urinary Drugs Market by Indication
9.1.5.3 Mexico Genito-urinary Drugs Market
9.1.5.3.1 Mexico Genito-urinary Drugs Market by Product
9.1.5.3.2 Mexico Genito-urinary Drugs Market by Indication
9.2. EUROPE
9.2.1 Europe Genito-urinary Drugs Market Overview
9.2.2 Europe Genito-urinary Drugs Market Forecasts and Analysis
9.2.3 Europe Genito-urinary Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Genito-urinary Drugs Market Forecasts and Analysis - By Indication
9.2.5 Europe Genito-urinary Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Genito-urinary Drugs Market
9.2.5.1.1 Germany Genito-urinary Drugs Market by Product
9.2.5.1.2 Germany Genito-urinary Drugs Market by Indication
9.2.5.2 France Genito-urinary Drugs Market
9.2.5.2.1 France Genito-urinary Drugs Market by Product
9.2.5.2.2 France Genito-urinary Drugs Market by Indication
9.2.5.3 Italy Genito-urinary Drugs Market
9.2.5.3.1 Italy Genito-urinary Drugs Market by Product
9.2.5.3.2 Italy Genito-urinary Drugs Market by Indication
9.2.5.4 Spain Genito-urinary Drugs Market
9.2.5.4.1 Spain Genito-urinary Drugs Market by Product
9.2.5.4.2 Spain Genito-urinary Drugs Market by Indication
9.2.5.5 United Kingdom Genito-urinary Drugs Market
9.2.5.5.1 United Kingdom Genito-urinary Drugs Market by Product
9.2.5.5.2 United Kingdom Genito-urinary Drugs Market by Indication
9.2.5.6 Rest of Europe Genito-urinary Drugs Market
9.2.5.6.1 Rest of Europe Genito-urinary Drugs Market by Product
9.2.5.6.2 Rest of Europe Genito-urinary Drugs Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Genito-urinary Drugs Market Overview
9.3.2 Asia-Pacific Genito-urinary Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Genito-urinary Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Genito-urinary Drugs Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Genito-urinary Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Genito-urinary Drugs Market
9.3.5.1.1 Australia Genito-urinary Drugs Market by Product
9.3.5.1.2 Australia Genito-urinary Drugs Market by Indication
9.3.5.2 China Genito-urinary Drugs Market
9.3.5.2.1 China Genito-urinary Drugs Market by Product
9.3.5.2.2 China Genito-urinary Drugs Market by Indication
9.3.5.3 India Genito-urinary Drugs Market
9.3.5.3.1 India Genito-urinary Drugs Market by Product
9.3.5.3.2 India Genito-urinary Drugs Market by Indication
9.3.5.4 Japan Genito-urinary Drugs Market
9.3.5.4.1 Japan Genito-urinary Drugs Market by Product
9.3.5.4.2 Japan Genito-urinary Drugs Market by Indication
9.3.5.5 South Korea Genito-urinary Drugs Market
9.3.5.5.1 South Korea Genito-urinary Drugs Market by Product
9.3.5.5.2 South Korea Genito-urinary Drugs Market by Indication
9.3.5.6 Rest of Asia-Pacific Genito-urinary Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Genito-urinary Drugs Market by Product
9.3.5.6.2 Rest of Asia-Pacific Genito-urinary Drugs Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Genito-urinary Drugs Market Overview
9.4.2 Middle East and Africa Genito-urinary Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Genito-urinary Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Genito-urinary Drugs Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Genito-urinary Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Genito-urinary Drugs Market
9.4.5.1.1 South Africa Genito-urinary Drugs Market by Product
9.4.5.1.2 South Africa Genito-urinary Drugs Market by Indication
9.4.5.2 Saudi Arabia Genito-urinary Drugs Market
9.4.5.2.1 Saudi Arabia Genito-urinary Drugs Market by Product
9.4.5.2.2 Saudi Arabia Genito-urinary Drugs Market by Indication
9.4.5.3 U.A.E Genito-urinary Drugs Market
9.4.5.3.1 U.A.E Genito-urinary Drugs Market by Product
9.4.5.3.2 U.A.E Genito-urinary Drugs Market by Indication
9.4.5.4 Rest of Middle East and Africa Genito-urinary Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Genito-urinary Drugs Market by Product
9.4.5.4.2 Rest of Middle East and Africa Genito-urinary Drugs Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Genito-urinary Drugs Market Overview
9.5.2 South and Central America Genito-urinary Drugs Market Forecasts and Analysis
9.5.3 South and Central America Genito-urinary Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Genito-urinary Drugs Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Genito-urinary Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Genito-urinary Drugs Market
9.5.5.1.1 Brazil Genito-urinary Drugs Market by Product
9.5.5.1.2 Brazil Genito-urinary Drugs Market by Indication
9.5.5.2 Argentina Genito-urinary Drugs Market
9.5.5.2.1 Argentina Genito-urinary Drugs Market by Product
9.5.5.2.2 Argentina Genito-urinary Drugs Market by Indication
9.5.5.3 Rest of South and Central America Genito-urinary Drugs Market
9.5.5.3.1 Rest of South and Central America Genito-urinary Drugs Market by Product
9.5.5.3.2 Rest of South and Central America Genito-urinary Drugs Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GENITO-URINARY DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENITO-URINARY DRUGS MARKET, KEY COMPANY PROFILES
12.1. MELINTA THERAPEUTICS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CIPLA USA INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALLERGAN PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO. INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTELLAS PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASTRAZENECA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRISTOL-MYERS SQUIBB COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Melinta Therapeutics Inc.
2. Cipla USA Inc.
3. Allergan PLC
4. Merck & Co. Inc.
5. Pfizer Inc.
6. Astellas Pharma
7. GlaxoSmithKline plc
8. Teva Pharmaceutical Industries Ltd.
9. AstraZeneca
10. Bristol-Myers Squibb Company
11. Novartis AG
12. Eli Lilly and Company
13. Advanz Pharmaceutical
TIPRE00021893
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking